Post-EPBD (n=235) | Post-EST (n=126) | ||||||
---|---|---|---|---|---|---|---|
Total | GB in situ | With GB stone | Total | GB in situ | With GB stone | ||
(n=235) | (n=150) | (n=110) | (n=126) | (n=68) | (n-48) | ||
Pneumobilia | 21 (8.9)6-160 | — | — | 50 (40)6-160 | — | — | |
Recurrent CBD stones | 23 (10) | 14 (9.3) | 10 (9.1) | 18 (14) | 7 (10) | 5 (10) | |
Cholangitis | 0 | 0 | 0 | 4 (3.2) | 3 (4.4) | 2 (4.2) | |
Cholecystitis | — | 3 (2.0) | 3 (2.7) | — | 6 (8.8) | 5 (10) |
EPBD, endoscopic papillary balloon dilation; CBD, common bile duct; EST, endoscopic sphincterotomy; GB, gall bladder.
↵6-160 p<0.01.